Analyst Ratings for Tenet Healthcare (THC)
THC Rating Summary
THC Price Target Summary
- Highest: $51.00 (CRT Capital)
- Lowest: $5.00 (BMO Capital)
- Average: $27.67
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$27.67 (-38.4%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/29/2013 | Baird | Upgrade | Outperform (Neutral) |
N/A (N/A) |
41.16 | 44.89 | 9.06% | Details |
| 4/29/2013 | UBS | Upgrade | Buy (Neutral) |
N/A (N/A) |
41.16 | 44.89 | 9.06% | Details |
| 4/10/2013 | Deutsche Bank | Downgrade | Hold (Buy) |
46.00 (N/A) |
43.52 | 44.89 | 3.15% | Details |
| 3/15/2013 | Ameriprise Financial | New Coverage | Buy (N/A) |
N/A (N/A) |
44.96 | 44.89 | -0.16% | Details |
| 3/8/2013 | CRT Capital | Upgrade | Buy (Fairly Valued) |
51.00 (N/A) |
41.76 | 44.89 | 7.5% | Details |
| 1/24/2013 | Raymond James | Upgrade | Outperform (Market Perform) |
45.00 (N/A) |
37.76 | 44.89 | 18.88% | Details |
| 1/17/2013 | Morgan Stanley | New Coverage | Equalweight (N/A) |
N/A (N/A) |
35.75 | 44.89 | 25.57% | Details |
| 1/11/2013 | BofA/Merrill Lynch | Upgrade | Buy (Neutral) |
N/A (N/A) |
33.16 | 44.89 | 35.37% | Details |
| 1/3/2013 | Imperial Capital | Upgrade | Outperform (In-Line) |
40.00 (20.00) |
33.39 | 44.89 | 34.44% | Details |
| 12/18/2012 | JPMorgan | New Coverage | Overweight (N/A) |
41.00 (N/A) |
31.18 | 44.89 | 43.97% | Details |
| 9/26/2012 | SunTrust Robinson Humphrey | New Coverage | Neutral (N/A) |
N/A (N/A) |
6.10 | 44.89 | 635.9% | Details |
| 6/29/2012 | Wells Fargo | Upgrade | Outperform (Market Perform) |
8.00 (N/A) |
5.25 | 44.89 | 755.05% | Details |
| 6/11/2012 | Citi | Upgrade | Buy (Sell) |
N/A (N/A) |
4.68 | 44.89 | 859.19% | Details |
| 12/2/2011 | BMO Capital | New Coverage | Market Perform (N/A) |
5.00 (N/A) |
4.68 | 44.89 | 859.19% | Details |
| 11/16/2011 | Leerink Swann | Downgrade | Market Perform (N/A) |
6.50 (N/A) |
5.07 | 44.89 | 785.4% | Details |
